These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10609113)

  • 21. 5-HT3 antagonists and ligands for dopamine D1- and autoreceptors offer new leads for antipsychotic drugs.
    Abbott A
    Trends Pharmacol Sci; 1990 Feb; 11(2):49-51. PubMed ID: 1969187
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome caused by dopamine depleting drugs.
    Login IS; Cronin MJ; MacLeod RM
    Neurology; 1982 Feb; 32(2):218-9. PubMed ID: 6119652
    [No Abstract]   [Full Text] [Related]  

  • 23. Computer-aided molecular modelling applied to the dopaminergic system.
    Chrétien JR; Boudon A
    Prog Clin Biol Res; 1989; 291():243-6. PubMed ID: 2567009
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia].
    Fog R
    Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506
    [No Abstract]   [Full Text] [Related]  

  • 25. Antipsychotic agents of the future.
    Gershon S
    Hosp Community Psychiatry; 1987 Nov; 38(11):1141. PubMed ID: 2889658
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmacokinetic effect of haloperidol on DA receptors].
    Giorgobiani IB; Kitiashvili SA
    Georgian Med News; 2005 Mar; (120):68-70. PubMed ID: 15855705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 29. [Medicinal action and efficacy of neuroleptics].
    Suzuki H; Akimoto T; Gen K; Aoba A
    Ryoikibetsu Shokogun Shirizu; 2003; (38):169-71. PubMed ID: 12876957
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multiplicity of dopamine receptors].
    Inoue A; Nakata Y
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1008-12. PubMed ID: 10771666
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical example of recovery from psychosis in the context of the theory of psychosis as a state of aberrant salience].
    Murawiec S
    Psychiatr Pol; 2005; 39(2):315-25. PubMed ID: 15881626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action.
    Kapur S; Seeman P
    J Psychiatry Neurosci; 2000 Mar; 25(2):161-6. PubMed ID: 10740989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An update of fast-off dopamine D2 atypical antipsychotics.
    Seeman P
    Am J Psychiatry; 2005 Oct; 162(10):1984-5. PubMed ID: 16199855
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in extracellular dopamine in the rat globus pallidus induced by typical and atypical antipsychotic drugs.
    Fuchs H; Hauber W
    Neurochem Int; 2004 Dec; 45(7):1029-38. PubMed ID: 15337302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex.
    Pira L; Mongeau R; Pani L
    Eur J Pharmacol; 2004 Nov; 504(1-2):61-4. PubMed ID: 15507222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine D4 receptors and mechanisms of antipsychotic atypicality.
    Wong AH; Van Tol HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limbic selective neuroleptics.
    Bischoff S
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():265A-266A. PubMed ID: 1354032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.